Trials / Conditions / Clostridium Difficile-Associated Diarrhea

Clostridium Difficile-Associated Diarrhea

6 registered clinical trials studyying Clostridium Difficile-Associated Diarrhea.

Status	Trial	Sponsor	Phase
Completed	Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-ass NCT01591863	Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release NCT01559545	Dr. Reddy's Laboratories Limited	Phase 2
Withdrawn	Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridi NCT00747071	Hadassah Medical Organization	Phase 2 / Phase 3
Completed	Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile- NCT00958308	Bio-K Plus International Inc.	Phase 3
Completed	A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea NCT00034294	Genzyme, a Sanofi Company	Phase 2
Withdrawn	Probiotics in Hospitalized Patients Study NCT01596153	South Shore Hospital	N/A